Analyze Diet
Journal of virology1987; 61(12); 3783-3789; doi: 10.1128/JVI.61.12.3783-3789.1987

Role of the host immune response in selection of equine infectious anemia virus variants.

Abstract: Equine infectious anemia virus was isolated from peripheral blood leukocytes collected during two early febrile cycles of an experimentally infected horse. RNase T1-resistant oligonucleotide fingerprint analyses indicated that the nucleotide sequences of the isolates differed by approximately 0.25% and that the differences appeared randomly distributed throughout the genome. Serum collected in the interval between virus isolations was able to distinguish the isolates by membrane immunofluorescence on live cells. However, no neutralizing antibody was detected in the interval between virus isolations. In fact, multiple clinical cycles occurred before the development of a neutralizing antibody response, indicating that viral neutralization might not be the mechanism for selection of antigenic variants. The ability of early immune sera to recognize variant specific antigens on the surface of infected cells suggested that immune selection occurs through recognition and elimination of certain virus-infected cells. Alternately, the random distribution of the genomic differences observed between the two isolates may indicate that equine infectious anemia virus variants emerge as a result of nonimmunological selection processes.
Publication Date: 1987-12-01 PubMed ID: 2446008PubMed Central: PMC255993DOI: 10.1128/JVI.61.12.3783-3789.1987Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research paper explores the role of the host’s immune response in the selection of variants of the Equine Infectious Anemia Virus (EIAV). The study reveals that immune system responses possibly contribute to recognizing and eliminating certain versions of the virus, although neutralizing antibodies do not appear to play a significant part in this process.

Methodology and Investigation

  • The researchers isolated EIAV from a horse’s peripheral blood leukocytes, white blood cells that play an essential role in the immune system, during two early feverish cycles following experimental infection.
  • They then analysed the isolates using RNase T1-resistant oligonucleotide fingerprint analysis. This technique allows researchers to determine the nucleotide sequence, which can be thought of as the DNA’s “blueprint.”
  • The research discovered that the isolates’ nucleotide sequences were approximately 0.25% different, indicating natural variation between the samples. Moreover, these differences appeared to be randomly distributed throughout the genetic material.

Findings and Implications

  • The research identified that serum, the component that makes up the majority of blood plasma, collected between the virus isolations could differentiate the isolates by live-cell membrane immunofluorescence. This process enables researchers to detect specific proteins in cells using fluorescent dyes.
  • Interestingly, no neutralizing antibody was found between the virus isolations. Neutralizing antibodies disable pathogens, rendering them harmless to the body. Multiple clinical cycles also occurred before the development of a neutralizing antibody response. This suggests that neutralization might not be the main mechanism for selecting antigenic variants.
  • The early immune serum’s ability to recognize variant-specific antigens on the surface of infected cells suggested that immune selection occurs through recognizing and eliminating specific virus-infected cells. This highlights the critical role the immune system might play in managing such infections.
  • Alternatively, the researchers also suggested that non-immunological selection processes might give rise to EIAV variants, given the observation of the random distribution of genomic differences between the two isolates.

Conclusion

  • The paper concludes that the host immune response seemingly plays a part in the selection of EIAV genetic variants, particularly through recognizing and eliminating certain virus-infected cells. However, it isn’t the neutralizing antibodies that facilitate this process, contrary to what might be expected.
  • Still, the non-immunological selection processes might also play an equally significant role, given the genomic differences’ random distribution. This potentially opens new lines of enquiry into understanding how variants of viruses like EIAV emerge and adapt.

Cite This Article

APA
Carpenter S, Evans LH, Sevoian M, Chesebro B. (1987). Role of the host immune response in selection of equine infectious anemia virus variants. J Virol, 61(12), 3783-3789. https://doi.org/10.1128/JVI.61.12.3783-3789.1987

Publication

ISSN: 0022-538X
NlmUniqueID: 0113724
Country: United States
Language: English
Volume: 61
Issue: 12
Pages: 3783-3789

Researcher Affiliations

Carpenter, S
  • Laboratory of Persistent Viral Diseases, National Institute of Allergy and Infectious Diseases, Rocky Mountain Laboratories, Hamilton, Montana 59840.
Evans, L H
    Sevoian, M
      Chesebro, B

        MeSH Terms

        • Animals
        • Antibodies, Viral / biosynthesis
        • Antigenic Variation
        • Antigens, Viral / immunology
        • Base Sequence
        • Cross Reactions
        • Epitopes / immunology
        • Equine Infectious Anemia / immunology
        • Equine Infectious Anemia / microbiology
        • Fluorescent Antibody Technique
        • Genes, Viral
        • Horses
        • Infectious Anemia Virus, Equine / genetics
        • Infectious Anemia Virus, Equine / immunology
        • Nucleotide Mapping

        References

        This article includes 35 references
        1. Kono Y. Viremia and immunological responses in horses infected with equine infectious anemia virus.. Natl Inst Anim Health Q (Tokyo) 1969 Spring;9(1):1-9.
          pubmed: 4306393
        2. Henderson LE, Sowder RC, Smythers GW, Oroszlan S. Chemical and immunological characterizations of equine infectious anemia virus gag-encoded proteins.. J Virol 1987 Apr;61(4):1116-24.
        3. Nakajima H, Tajima M, Tanaka S, Ushimi C. Physicochemical studies of equine infectionus anemia virus. 3. Purification and electron microscopic observation of the virus.. Arch Gesamte Virusforsch 1969;28(3):348-60.
          pubmed: 4195623doi: 10.1007/BF01240949google scholar: lookup
        4. Kono Y, Kobayashi K, Fukunaga Y. Serological comparison among various strains of equine infectious anemia virus.. Arch Gesamte Virusforsch 1971;34(3):202-8.
          pubmed: 4330134doi: 10.1007/BF01242993google scholar: lookup
        5. Crawford TB, McGuire TC, Henson JB. Detection of equine infectious anemia virus in vitro by immunofluorescence.. Arch Gesamte Virusforsch 1971;34(4):332-9.
          pubmed: 4330258doi: 10.1007/BF01242979google scholar: lookup
        6. Kono Y, Kobayashi K, Fukunaga Y. Antigenic drift of equine infectious anemia virus in chronically infected horses.. Arch Gesamte Virusforsch 1973;41(1):1-10.
          pubmed: 4123810doi: 10.1007/BF01249923google scholar: lookup
        7. Bonner WM, Laskey RA. A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.. Eur J Biochem 1974 Jul 1;46(1):83-8.
        8. Gudnadóttir M. Visna-maedi in sheep.. Prog Med Virol 1974;18(0):336-49.
          pubmed: 4370615
        9. McGuire TC, Crawford TB, Henson JB. Equine infectious anemia: detection of infections virus-antibody complexes in the serum.. Immunol Commun 1972;1(6):545-51.
          pubmed: 4141690doi: 10.3109/08820137209022963google scholar: lookup
        10. Kessler SW. Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.. J Immunol 1975 Dec;115(6):1617-24.
          pubmed: 1102604
        11. Narayan O, Griffin DE, Chase J. Antigenic shift of visna virus in persistently infected sheep.. Science 1977 Jul 22;197(4301):376-8.
          pubmed: 195339doi: 10.1126/science.195339google scholar: lookup
        12. Gonda MA, Charman HP, Walker JL, Coggins L. Scanning and transmission electron microscopic study of equine infectious anemia virus.. Am J Vet Res 1978 May;39(5):731-40.
          pubmed: 215061
        13. Scott JV, Stowring L, Haase AT, Narayan O, Vigne R. Antigenic variation in visna virus.. Cell 1979 Oct;18(2):321-7.
          pubmed: 227603doi: 10.1016/0092-8674(79)90051-5google scholar: lookup
        14. Evans LH, Duesberg PH, Troxler DH, Scolnick EM. Spleen focus-forming Friend virus: identification of genomic RNA and its relationship to helper virus RNA.. J Virol 1979 Jul;31(1):133-46.
          pubmed: 501795doi: 10.1128/JVI.31.1.133-146.1979google scholar: lookup
        15. Clements JE, Pedersen FS, Narayan O, Haseltine WA. Genomic changes associated with antigenic variation of visna virus durig persistent infection.. Proc Natl Acad Sci U S A 1980 Aug;77(8):4454-8.
          pubmed: 6254026doi: 10.1073/pnas.77.8.4454google scholar: lookup
        16. Parekh B, Issel CJ, Montelaro RC. Equine infectious anemia virus, a putative lentivirus, contains polypeptides analogous to prototype-C oncornaviruses.. Virology 1980 Dec;107(2):520-5.
          pubmed: 6256947doi: 10.1016/0042-6822(80)90319-0google scholar: lookup
        17. Narayan O, Clements JE, Griffin DE, Wolinsky JS. Neutralizing antibody spectrum determines the antigenic profiles of emerging mutants of visna virus.. Infect Immun 1981 Jun;32(3):1045-50.
        18. Clements JE, D'Antonio N, Narayan O. Genomic changes associated with antigenic variation of visna virus. II. Common nucleotide sequence changes detected in variants from independent isolations.. J Mol Biol 1982 Jul 5;158(3):415-34.
          pubmed: 6182297doi: 10.1016/0022-2836(82)90207-8google scholar: lookup
        19. Thormar H, Barshatzky MR, Arnesen K, Kozlowski PB. The emergence of antigenic variants is a rare event in long-term visna virus infection in vivo.. J Gen Virol 1983 Jul;64 (Pt 7):1427-32.
          pubmed: 6306144doi: 10.1099/0022-1317-64-7-1427google scholar: lookup
        20. Lutley R, Pétursson G, Pálsson PA, Georgsson G, Klein J, Nathanson N. Antigenic drift in visna: virus variation during long-term infection of Icelandic sheep.. J Gen Virol 1983 Jul;64 (Pt 7):1433-40.
          pubmed: 6306145doi: 10.1099/0022-1317-64-7-1433google scholar: lookup
        21. Evans LH, Cloyd MW. Generation of mink cell focus-forming viruses by Friend murine leukemia virus: recombination with specific endogenous proviral sequences.. J Virol 1984 Mar;49(3):772-81.
          pubmed: 6422051doi: 10.1128/JVI.49.3.772-781.1984google scholar: lookup
        22. Evans KS, Carpenter SL, Sevoian M. Detection of equine infectious anemia virus in horse leukocyte cultures derived from horses in various stages of equine infectious anemia viral infection.. Am J Vet Res 1984 Jan;45(1):20-5.
          pubmed: 6322623
        23. Payne S, Parekh B, Montelaro RC, Issel CJ. Genomic alterations associated with persistent infections by equine infectious anaemia virus, a retrovirus.. J Gen Virol 1984 Aug;65 ( Pt 8):1395-9.
          pubmed: 6086822doi: 10.1099/0022-1317-65-8-1395google scholar: lookup
        24. Montelaro RC, Parekh B, Orrego A, Issel CJ. Antigenic variation during persistent infection by equine infectious anemia virus, a retrovirus.. J Biol Chem 1984 Aug 25;259(16):10539-44.
          pubmed: 6206055
        25. Sitbon M, Nishio J, Wehrly K, Lodmell D, Chesebro B. Use of a focal immunofluorescence assay on live cells for quantitation of retroviruses: distinction of host range classes in virus mixtures and biological cloning of dual-tropic murine leukemia viruses.. Virology 1985 Feb;141(1):110-8.
          pubmed: 2983493doi: 10.1016/0042-6822(85)90187-4google scholar: lookup
        26. Cheevers WP, McGuire TC. Equine infectious anemia virus: immunopathogenesis and persistence.. Rev Infect Dis 1985 Jan-Feb;7(1):83-8.
          pubmed: 2984759doi: 10.1093/clinids/7.1.83google scholar: lookup
        27. Casey JM, Kim Y, Andersen PR, Watson KF, Fox JL, Devare SG. Human T-cell lymphotropic virus type III: immunologic characterization and primary structure analysis of the major internal protein, p24.. J Virol 1985 Aug;55(2):417-23.
          pubmed: 2410630doi: 10.1128/JVI.55.2.417-423.1985google scholar: lookup
        28. Chiu IM, Yaniv A, Dahlberg JE, Gazit A, Skuntz SF, Tronick SR, Aaronson SA. Nucleotide sequence evidence for relationship of AIDS retrovirus to lentiviruses.. Nature 1985 Sep 26-Oct 2;317(6035):366-8.
          pubmed: 2995822doi: 10.1038/317366a0google scholar: lookup
        29. Salinovich O, Payne SL, Montelaro RC, Hussain KA, Issel CJ, Schnorr KL. Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection.. J Virol 1986 Jan;57(1):71-80.
          pubmed: 3001367doi: 10.1128/JVI.57.1.71-80.1986google scholar: lookup
        30. Stephens RM, Casey JW, Rice NR. Equine infectious anemia virus gag and pol genes: relatedness to visna and AIDS virus.. Science 1986 Feb 7;231(4738):589-94.
          pubmed: 3003905doi: 10.1126/science.3003905google scholar: lookup
        31. Gonda MA, Braun MJ, Clements JE, Pyper JM, Wong-Staal F, Gallo RC, Gilden RV. Human T-cell lymphotropic virus type III shares sequence homology with a family of pathogenic lentiviruses.. Proc Natl Acad Sci U S A 1986 Jun;83(11):4007-11.
          pubmed: 2424014doi: 10.1073/pnas.83.11.4007google scholar: lookup
        32. Coffin JM. Genetic variation in AIDS viruses.. Cell 1986 Jul 4;46(1):1-4.
          pubmed: 3013415doi: 10.1016/0092-8674(86)90851-2google scholar: lookup
        33. Haase AT. Pathogenesis of lentivirus infections.. Nature 1986 Jul 10-16;322(6075):130-6.
          pubmed: 2425264doi: 10.1038/322130a0google scholar: lookup
        34. Rushlow K, Olsen K, Stiegler G, Payne SL, Montelaro RC, Issel CJ. Lentivirus genomic organization: the complete nucleotide sequence of the env gene region of equine infectious anemia virus.. Virology 1986 Dec;155(2):309-21.
          pubmed: 2431539doi: 10.1016/0042-6822(86)90195-9google scholar: lookup
        35. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.. Nature 1970 Aug 15;227(5259):680-5.
          pubmed: 5432063doi: 10.1038/227680a0google scholar: lookup

        Citations

        This article has been cited 31 times.
        1. Taylor SD, Leib SR, Carpenter S, Mealey RH. Selection of a rare neutralization-resistant variant following passive transfer of convalescent immune plasma in equine infectious anemia virus-challenged SCID horses. J Virol 2010 Jul;84(13):6536-48.
          doi: 10.1128/JVI.00218-10pubmed: 20392850google scholar: lookup
        2. Chung C, Mealey RH, McGuire TC. Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horses. Virology 2005 Nov 25;342(2):228-39.
          doi: 10.1016/j.virol.2005.07.033pubmed: 16139857google scholar: lookup
        3. Mealey RH, Sharif A, Ellis SA, Littke MH, Leib SR, McGuire TC. Early detection of dominant Env-specific and subdominant Gag-specific CD8+ lymphocytes in equine infectious anemia virus-infected horses using major histocompatibility complex class I/peptide tetrameric complexes. Virology 2005 Aug 15;339(1):110-26.
          doi: 10.1016/j.virol.2005.05.025pubmed: 15979679google scholar: lookup
        4. Chung C, Mealey RH, McGuire TC. CTL from EIAV carrier horses with diverse MHC class I alleles recognize epitope clusters in Gag matrix and capsid proteins. Virology 2004 Sep 15;327(1):144-54.
          doi: 10.1016/j.virol.2004.06.035pubmed: 15327905google scholar: lookup
        5. Mealey RH, Leib SR, Pownder SL, McGuire TC. Adaptive immunity is the primary force driving selection of equine infectious anemia virus envelope SU variants during acute infection. J Virol 2004 Sep;78(17):9295-305.
        6. Mealey RH, Zhang B, Leib SR, Littke MH, McGuire TC. Epitope specificity is critical for high and moderate avidity cytotoxic T lymphocytes associated with control of viral load and clinical disease in horses with equine infectious anemia virus. Virology 2003 Sep 1;313(2):537-52.
          doi: 10.1016/s0042-6822(03)00344-1pubmed: 12954220google scholar: lookup
        7. Gould SJ, Booth AM, Hildreth JE. The Trojan exosome hypothesis. Proc Natl Acad Sci U S A 2003 Sep 16;100(19):10592-7.
          doi: 10.1073/pnas.1831413100pubmed: 12947040google scholar: lookup
        8. Maury W, Wright PJ, Bradley S. Characterization of a cytolytic strain of equine infectious anemia virus. J Virol 2003 Feb;77(4):2385-99.
        9. Lonning SM, Zhang W, Leib SR, McGuire TC. Detection and induction of equine infectious anemia virus-specific cytotoxic T-lymphocyte responses by use of recombinant retroviral vectors. J Virol 1999 Apr;73(4):2762-9.
        10. Zhang W, Lonning SM, McGuire TC. Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection. J Virol 1998 Dec;72(12):9612-20.
        11. Belshan M, Harris ME, Shoemaker AE, Hope TJ, Carpenter S. Biological characterization of Rev variation in equine infectious anemia virus. J Virol 1998 May;72(5):4421-6.
        12. Leroux C, Issel CJ, Montelaro RC. Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony. J Virol 1997 Dec;71(12):9627-39.
        13. Hammond SA, Cook SJ, Lichtenstein DL, Issel CJ, Montelaro RC. Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process. J Virol 1997 May;71(5):3840-52.
        14. Wang WK, Essex M, McLane MF, Mayer KH, Hsieh CC, Brumblay HG, Seage G, Lee TH. Pattern of gp120 sequence divergence linked to a lack of clinical progression in human immunodeficiency virus type 1 infection. Proc Natl Acad Sci U S A 1996 Jun 25;93(13):6693-7.
          doi: 10.1073/pnas.93.13.6693pubmed: 8692880google scholar: lookup
        15. Beisel CE, Edwards JF, Dunn LL, Rice NR. Analysis of multiple mRNAs from pathogenic equine infectious anemia virus (EIAV) in an acutely infected horse reveals a novel protein, Ttm, derived from the carboxy terminus of the EIAV transmembrane protein. J Virol 1993 Feb;67(2):832-42.
          doi: 10.1128/JVI.67.2.832-842.1993pubmed: 8419648google scholar: lookup
        16. Carpenter S, Nadin-Davis SA, Wannemuehler Y, Roth JA. Identification of transactivation-response sequences in the long terminal repeat of bovine immunodeficiency-like virus. J Virol 1993 Jul;67(7):4399-403.
        17. Alexandersen S, Carpenter S, Christensen J, Storgaard T, Viuff B, Wannemuehler Y, Belousov J, Roth JA. Identification of alternatively spliced mRNAs encoding potential new regulatory proteins in cattle infected with bovine leukemia virus. J Virol 1993 Jan;67(1):39-52.
          doi: 10.1128/JVI.67.1.39-52.1993pubmed: 8380084google scholar: lookup
        18. Kim CH, Casey JW. In vivo replicative status and envelope heterogeneity of equine infectious anemia virus in an inapparent carrier. J Virol 1994 Apr;68(4):2777-80.
        19. Sellon DC, Fuller FJ, McGuire TC. The immunopathogenesis of equine infectious anemia virus. Virus Res 1994 May;32(2):111-38.
          doi: 10.1016/0168-1702(94)90038-8pubmed: 8067050google scholar: lookup
        20. Carpenter S, Fehr MJ, Kraus GA, Petrich JW. Chemiluminescent activation of the antiviral activity of hypericin: a molecular flashlight. Proc Natl Acad Sci U S A 1994 Dec 6;91(25):12273-7.
          doi: 10.1073/pnas.91.25.12273pubmed: 7991618google scholar: lookup
        21. Steinhauer DA, de la Torre JC, Meier E, Holland JJ. Extreme heterogeneity in populations of vesicular stomatitis virus. J Virol 1989 May;63(5):2072-80.
        22. Carpenter S, Chesebro B. Change in host cell tropism associated with in vitro replication of equine infectious anemia virus. J Virol 1989 Jun;63(6):2492-6.
        23. Simmonds P, Balfe P, Ludlam CA, Bishop JO, Brown AJ. Analysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1. J Virol 1990 Dec;64(12):5840-50.
        24. Whetter L, Archambault D, Perry S, Gazit A, Coggins L, Yaniv A, Clabough D, Dahlberg J, Fuller F, Tronick S. Equine infectious anemia virus derived from a molecular clone persistently infects horses. J Virol 1990 Dec;64(12):5750-6.
        25. Balfe P, Simmonds P, Ludlam CA, Bishop JO, Brown AJ. Concurrent evolution of human immunodeficiency virus type 1 in patients infected from the same source: rate of sequence change and low frequency of inactivating mutations. J Virol 1990 Dec;64(12):6221-33.
        26. Perryman LE, O'Rourke KI, Mason PH, McGuire TC. Equine monoclonal antibodies recognize common epitopes on variants of equine infectious anaemia virus. Immunology 1990 Dec;71(4):592-4.
          pubmed: 1703988
        27. Alexandersen S, Carpenter S. Characterization of variable regions in the envelope and S3 open reading frame of equine infectious anemia virus. J Virol 1991 Aug;65(8):4255-62.
        28. Grimaila RJ, Fuller BA, Rennert PD, Nelson MB, Hammarskjöld ML, Potts B, Murray M, Putney SD, Gray G. Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization. J Virol 1992 Apr;66(4):1875-83.
        29. Perry ST, Flaherty MT, Kelley MJ, Clabough DL, Tronick SR, Coggins L, Whetter L, Lengel CR, Fuller F. The surface envelope protein gene region of equine infectious anemia virus is not an important determinant of tropism in vitro. J Virol 1992 Jul;66(7):4085-97.
        30. Monk RJ, Malik FG, Stokesberry D, Evans LH. Direct determination of the point mutation rate of a murine retrovirus. J Virol 1992 Jun;66(6):3683-9.
        31. Carpenter S, Miller LD, Alexandersen S, Whetstone CA, VanDerMaaten MJ, Viuff B, Wannemuehler Y, Miller JM, Roth JA. Characterization of early pathogenic effects after experimental infection of calves with bovine immunodeficiency-like virus. J Virol 1992 Feb;66(2):1074-83.